HomeInsightsResults

Aarey Drugs & Pharmaceuticals Ltd Quarterly Result

Aarey Drugs & Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

5.6 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS

Net Profit

₹ 1.6

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Aarey Drugs & Pharmaceuticals Ltd for the Sep '24 is ₹ 105.16 crore as compare to the Jun '24 revenue of ₹ 128.49 crore. This represent the decline of -18.157057%.
  • The ebitda of Aarey Drugs & Pharmaceuticals Ltd for the Sep '24 is ₹ 3.74 crore as compare to the Jun '24 ebitda of ₹ 2.75 crore. This represent the growth of 36%.
  • The net profit of Aarey Drugs & Pharmaceuticals Ltd for the Sep '24 is ₹ 1.6 crore as compare to the Jun '24 net profit of ₹ 1.24 crore. This represent the growth of 29.032257%.

Results Analysis

Market Price of Aarey Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Aarey Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202457.23
21 Nov 202455.29
19 Nov 202455.6
18 Nov 202454.81
14 Nov 202455.87
13 Nov 202458.47
12 Nov 202461.54
11 Nov 202464.77
08 Nov 202463.51
07 Nov 202465.89

Historical Revenue of Aarey Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Aarey Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Aarey Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Aarey Drugs & Pharmaceuticals Ltd News Hub

News

Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

07 Nov 202414:25

News

Aarey Drugs & Pharmaceuticals to conduct board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

25 Sep 202415:25

News

Aarey Drugs & Pharmaceuticals schedules AGM

Aarey Drugs & Pharmaceuticals announced that the 34th Annual General Meeting (AGM) of the ...

Read more

19 Sep 202409:44

News

Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

10 Aug 202412:25

News

Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

28 May 202415:38

News

Aarey Drugs & Pharmaceuticals to consider Preferential Issue

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

20 Mar 202417:09

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Aarey Drugs Pharmaceuticals Ltd Quarterly Result

What is the EPS of Aarey Drugs & Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Aarey Drugs & Pharmaceuticals Ltd is 2.47. An EPS is the amount of net income attributed to each share of a common stock.

How is Aarey Drugs & Pharmaceuticals Ltd EPS calculated?

The EPS of Aarey Drugs & Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Aarey Drugs & Pharmaceuticals Ltd report its EPS?

Aarey Drugs & Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Aarey Drugs & Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Aarey Drugs & Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Aarey Drugs & Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Aarey Drugs & Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*